Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Provexis Share Price
  4. Provexis Share Regulatory News
  5. Directorate Change

Pin to quick picksProvexis Regulatory News (PXS)

Provexis Information

Share Price Information for Provexis (PXS)

Share Price is delayed by 15 minutes
Get Live Data
1.10    0.00 (0.00%)
Bid:
1.00
Ask:
1.10
Spread: 0.10 (10.00%)
Market Cap: £25.80m
PXS Live PriceLast checked at - London Stock Exchange

Intraday Provexis Share Chart

Directorate Change

17 Sep 2009 14:15

RNS Number : 2451Z
Provexis PLC
17 September 2009
Ā 

ļ»æ

17Ā September 2009Ā 

Provexis plc

("Provexis" or the "Company")

Directorate change

Provexis plc (PXS.L), the life-science business that discovers, develops and licenses scientifically-proven functional food, medical food and dietary supplement technologiesĀ today announces thatĀ Jonathan DigginesĀ isĀ stepping down withĀ immediate effect from his role as a Non-executiveĀ director of the Company.

Jonathan DigginesĀ joined the Board asĀ a Non-executive directorĀ onĀ 24 April 2007.

Dawson Buck, Chairman of Provexis plc said:

"The Board would like to thankĀ Jonathan DigginesĀ for his contribution toĀ theĀ business over a period of considerable change, and wishes him well in his future."

ENQUIRIES

Provexis plc Tel 01753 752290

Stephen Moon,Ā CEO

Ian Ford, FD

ArbuthnotĀ Securities Limited Tel 020 7012 2000

Tom GriffithsĀ /Ā Alasdair Younie

END

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
BOALRMJTMMBBBIL
123456789
Date   Source Headline
20th May 20267:00 amRNSHolding(s) in Company
16th Apr 202612:37 pmRNSHolding(s) in Company
31st Dec 20258:22 amRNSHalf-year Financial Report
31st Dec 20258:22 amRNSHalf-year Financial Report
21st Nov 20251:38 pmRNSResult of AGM
30th Oct 20257:30 amRNSRestoration - Provexis plc
30th Oct 20257:00 amRNSFinal Results
1st Oct 20257:30 amRNSSuspension - Provexis PLC
30th Sep 20258:40 amRNSDelay in publication of annual accounts
7th Jan 20251:14 pmRNSGrant of Options and Warrants
31st Dec 20241:00 pmRNSTotal Voting Rights
31st Dec 20249:59 amRNSHalf-year Report
18th Dec 20247:00 amRNSPurchase of Fruitflow® II SD & royalty payment
25th Oct 20243:47 pmRNSResult of AGM
30th Sep 20247:00 amRNSFinal Results
30th Apr 20245:00 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSIssue of Equity - purchase of Fruitflow® II SD
29th Dec 202312:48 pmRNSHalf-year Report
26th Oct 20231:51 pmRNSResult of AGM
29th Sep 20237:00 amRNSFinal Results
30th Aug 20237:04 amRNSBYHEALTH regulatory filing with Chinese SAMR
3rd Apr 20237:00 amRNSCapital structure and funding update
24th Jan 202311:03 amRNSGrant of Share Options
30th Dec 20228:53 amRNSHalf-year Report
27th Oct 20221:12 pmRNSResult of AGM
14th Oct 20227:00 amRNSDirectorate Change
30th Sep 20227:00 amRNSFinal Results
22nd Jun 20227:00 amRNSTwo new agreements with DSM & patent application
31st May 20225:00 pmRNSTotal Voting Rights
17th May 202212:39 pmRNSExercise of Options and Total Voting Rights
31st Dec 20217:00 amRNSHalf-year Report
26th Nov 20214:41 pmRNSSecond Price Monitoring Extn
26th Nov 20214:36 pmRNSPrice Monitoring Extension
4th Nov 20211:30 pmRNSResult of AGM
4th Nov 202111:07 amRNSBy-Health Fruitflow agreement and support in R&D
1st Oct 20216:04 pmRNSGrant of Share Options
30th Sep 20217:00 amRNSFinal Results
9th Sep 20214:41 pmRNSSecond Price Monitoring Extn
9th Sep 20214:35 pmRNSPrice Monitoring Extension
24th Aug 20214:35 pmRNSPrice Monitoring Extension
22nd Jul 20214:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20214:35 pmRNSPrice Monitoring Extension
21st Jul 20214:41 pmRNSSecond Price Monitoring Extn
21st Jul 20214:36 pmRNSPrice Monitoring Extension
5th Jul 20214:35 pmRNSPrice Monitoring Extension
1st Jul 20214:40 pmRNSSecond Price Monitoring Extn
1st Jul 20214:35 pmRNSPrice Monitoring Extension
26th Feb 20215:00 pmRNSTotal Voting Rights
19th Feb 20217:30 amRNSDirector / PDMR notification
19th Feb 20217:00 amRNSPlacing of new ordinary shares to raise £50,000
123456789

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
VAL
ValiRx
LSE
-2.63%
LIT
Litigation Cap.
LSE
0.00%
JMF
JMF.L
LSE
0.00%
ARW
ARW.L
LSE
0.00%
AMS
Advanced Medical Solutions Group
LSE
2.08%
Trending
GGP
Greatland Resources
LSE
-0.42%
CAML
Central Asia Metals
LSE
-6.46%
MTL
Metals Exploration
LSE
-2.22%
MPL
Mercantile Ports & Logistics
LSE
3.33%
SOLG
SolGold
LSE
0.00%